Cencora, Inc. (NYSE:COR – Get Free Report) declared a quarterly dividend on Tuesday, November 3rd. Shareholders of record on Friday, November 13th will be paid a dividend of $0.66 per share on Monday, November 30th. This represents a $2.64 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Friday, November 13th. This is a 10.0% increase from Cencora’s previous quarterly dividend of $0.60.
Cencora has increased its dividend by an average of 0.1% per year over the last three years and has raised its dividend every year for the last 15 years. Cencora has a dividend payout ratio of 15.3% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Cencora to earn $21.60 per share next year, which means the company should continue to be able to cover its $2.64 annual dividend with an expected future payout ratio of 12.2%.
Cencora Stock Performance
Cencora stock opened at $348.54 on Wednesday. The firm’s fifty day moving average price is $326.05 and its 200-day moving average price is $317.23. The company has a debt-to-equity ratio of 3.01, a quick ratio of 0.59 and a current ratio of 0.94. The stock has a market cap of $66.51 billion, a P/E ratio of 19.45, a price-to-earnings-growth ratio of 1.79 and a beta of 0.58. Cencora has a fifty-two week low of $244.82 and a fifty-two week high of $377.54.
Cencora (NYSE:COR – Get Free Report) last announced its earnings results on Wednesday, November 4th. The company reported $4.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.58 by $0.08. Cencora had a net margin of 1.03% and a return on equity of 110.72%. The company had revenue of $88.35 billion during the quarter, compared to analyst estimates of $87.95 billion. During the same period in the previous year, the business earned $3.84 earnings per share. The firm’s quarterly revenue was up 5.5% compared to the same quarter last year. On average, equities research analysts expect that Cencora will post 19.58 earnings per share for the current fiscal year.
Cencora Company Profile
Cencora, formerly known as AmerisourceBergen, is a global pharmaceutical services company that connects pharmaceutical manufacturers with healthcare providers. Its core business includes sourcing and distributing medicines and other healthcare products to pharmacies, hospitals, health systems and other care providers. The company also provides services supporting specialty pharmaceuticals, including logistics, consulting and solutions for manufacturers and healthcare organizations. These services help manage the handling and delivery of complex medicines and support access to treatments.
Further Reading
- Five stocks we like better than Cencora
- Anthropic’s Trillion-Dollar IPO Could Give Cloud Giants a Double Win
- The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom
- 3 Insider Selling Stories; 3 Different Signals for Investors
- The Trade Desk Beats on Revenue, But the Fine Print Matters
Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.
